Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

The recent introduction of the “precision medicine” concept in oncology pushed cancer research to focus on dynamic measurable biomarkers able to predict responses to novel anticancer therapies in order to improve clinical outcomes. Recently, the involvement of extracellular vesicles (EVs) in cancer...

Full description

Bibliographic Details
Main Authors: D. Brocco, P. Lanuti, P. Simeone, G. Bologna, D. Pieragostino, M. C. Cufaro, V. Graziano, M. Peri, P. Di Marino, M. De Tursi, A. Grassadonia, I. G. Rapposelli, L. Pierdomenico, E. Ercolino, F. Ciccocioppo, P. Del Boccio, M. Marchisio, C. Natoli, S. Miscia, N. Tinari
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Oncology
Online Access:http://dx.doi.org/10.1155/2019/5879616

Internet

http://dx.doi.org/10.1155/2019/5879616

Similar Items